DescriptionUpstate NY / Allergy Clinic w/ 4 Loc / ADD ON / $1.42M Adjusted EBITDA
Company Overview
The business is a multi-site specialty allergy, asthma, and immunology platform providing diagnostic testing, chronic disease management, and immunotherapy treatment across a regional footprint. Operating through an asset-light, outpatient model, the platform delivers care via a physician-led structure supported by nurse practitioners and physician assistants, enabling scalable clinical throughput and efficient utilization of provider time.
The company has established a strong position in an underserved market, benefiting from limited specialist supply and long patient wait times, which drive consistent inbound demand. Patient acquisition is primarily referral-driven through long-standing relationships with primary care physicians, pediatricians, and ENT specialists, with no reliance on paid marketing.
Revenue is highly recurring and predictable, anchored by immunotherapy programs where patients return weekly over multi-year treatment plans. This model supports high visit frequency, strong patient retention, and attractive unit economics. The platform currently operates across four locations, with built-in capacity for growth through extended clinic hours and additional provider utilization without requiring significant incremental capital investment. 
Key KPIs
• Revenue: ~$3.47M (2025) 
• Revenue Growth: ~9% (2023–2025) 
• Adjusted EBITDA: ~$1.42M 
• EBITDA Margin: ~41% 
• Locations: 4 outpatient clinics 
• Daily Patient Volume: ~20–26 scheduled visits + 40–50 immunotherapy visits 
• Recurring Visit Model: Weekly treatments over 3–5 year protocols 
• Payer Mix: ~50% Medicare/Medicaid with diversified commercial exposure 
• Staffing Model: ~18 employees with ~98% of visits handled by NPs/PAs